跳至主要内容
临床试验/NCT03861884
NCT03861884招募中不适用

Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)

Nottingham University Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2018年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
125
试验地点
2
主要终点
Neurocognitive scales on Birmingham Cognitive Screen (BCoS) Scores

研究概览

简要总结

This prospective study aims:

  1. to compare cognitive performance in different clinical groups of participants with mild cognitive impairment (MCI) or mild dementia [Alzheimer's Disease (AD), Vascular Cognitive Impairment (VCI) and Fronto-temporal Dementia (FTD)] to determine whether scores reveal differential profiles between the groups,
  2. to demonstrate differences in imaging markers between different dementia syndromes and healthy volunteers using ultra high-field MRI at 7T.

详细描述

The imaging arm of the study include:

  1. to demonstrate differences in brain iron levels between different dementia syndromes and healthy volunteers using ultra high-field MRI, quantitative susceptibility mapping (QSM) at 7T.
  2. to demonstrate variations in the resting oxygen usage as an important biomarker to discriminate between different dementia syndromes.
  3. to demonstrate cerebral blood flow changes in the brain, particularly in the hippocampus region, and its correlation with different dementia syndromes using Arterial Spin Labelling MRI technique.
  4. to demonstrate increased blood brain barrier leakage in the brain, particularly in the hippocampus region, and its correlation with Alzheimer's Disease (AD) and Vascular Cognitive Impairment (VCI) using a new dynamic contrast-enhanced MRI (DCE-MRI) technique.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to give informed consent.
  • Either pathological, genetic or imaging biomarker evidence to suggest Fronto-temporal Lobar Degeneration, Alzheimer's Disease or Vascular Cognitive Impairment, or defined clinical diagnoses.

排除标准

  • Lack of mental capacity to consent to study involvement.
  • Not speaking English before age 5 years.
  • Learning disability.
  • MRI contraindications

结局指标

主要结局

Neurocognitive scales on Birmingham Cognitive Screen (BCoS) Scores

时间窗: Through study completion (an average of one year)

cognitive sub scores in relation to clinical phenotype

次要结局

  • Structural imaging changes on MRI at 3T(Through study completion (an average of one year))
  • Susceptibility weighted mapping at 7T(Through study completion (an average of one year))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验